Modulim Granted Patent for a System and Method to Assess Diabetic Circulatory Complications
Irvine, CA—September 22, 2023— Modulim, the leader in point of care microvascular insights, announced the grant of United States Patent US11751769B2, titled “Systems and Methods for Assessing Diabetic Circulatory Complications.” This patent signifies a milestone for Modulim and the relevance of its solutions for diabetes patient management. The patent teaches Modulim’s novel approach to assess […]